Home > PS Ratio > JENBURKT PHARMACEUTICALS

JENBURKT PHARMACEUTICALS
PS (Price/Sales) Ratio

The Current P/S Ratio of JENBURKT PHARMACEUTICALS is 3.00.

Share Price ₹1,083.6Dec 29,2025
Market Cap ₹476.8 Cr
Sales-TTM₹159.0 CrTTM-Standalone Results
Price/Sales3.00xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for JENBURKT PHARMACEUTICALS
Please provide your vote to see the results
JENBURKT PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of JENBURKT PHARMACEUTICALS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of JENBURKT PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹476.8 Cr] as on Dec 29,2025

(/) Sales [ ₹159.0 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 3.00x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for JENBURKT PHARMACEUTICALS , the investors are currently willing to pay '3.00 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of JENBURKT PHARMACEUTICALS !

The chart below summarizes the trend in P/S Ratio of JENBURKT PHARMACEUTICALS over the last five years.

Historical PS (Price/Sales) ratio chart of JENBURKT PHARMACEUTICALS


PS Ratio Performance Analysis for JENBURKT PHARMACEUTICALS

- JENBURKT PHARMACEUTICALS 's latest p/e ratio is 3.00x.

- JENBURKT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.20x.

- JENBURKT PHARMACEUTICALS 's operated at median p/e ratio of 2.14x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, JENBURKT PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 2.94x.

- JENBURKT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 1.67x.


How does JENBURKT PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
JENBURKT PHARMACEUTICALS 159.03.00476.8
SUN PHARMACEUTICAL INDUSTRIES LTD54,964.07.50412,086.0
DIVIS LABORATORIES LTD10,029.016.91169,616.0
CIPLA LTD28,349.64.26120,713.0
TORRENT PHARMACEUTICALS LTD12,248.010.48128,361.0
DR REDDYS LABORATORIES LTD34,310.03.09105,881.0
MANKIND PHARMA LTD13,576.96.6390,069.9
ZYDUS LIFESCIENCES LTD24,493.93.7190,963.5
LUPIN LTD24,750.73.8494,991.3
AUROBINDO PHARMA LTD32,514.52.1469,638.1
ABBOTT INDIA LTD6,714.49.1561,440.3

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs JENBURKT PHARMACEUTICALS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.14x
Max industry PS 16.91x
Median industry PS 4.26x
Average industry PS 6.43x



You may also like the below Video Courses